Registered entities
Recursion Pharmaceuticals, Inc.
Reg. No. 6727635United States
RECURSION PHARMACEUTICALS, INC.
Reg. No. 1601830United States
RECURSION PHARMACEUTICALS LLC
Reg. No. 464099738United States
Innovation
69 patent families (29 granted) — focus: Physics & computing, Chemistry & metallurgy, Human necessities, Operations & transport; filing pace accelerating. Cited 1,460 times.
| Year | Filings |
|---|---|
| 2018 | 2 |
| 2019 | 2 |
| 2020 | 5 |
| 2021 | 9 |
| 2022 | 16 |
| 2023 | 14 |
| 2024 | 19 |
| 2025 | 37 |
| 2026 | 13 |
Investor mix
49 investors on record; lead investors include Baillie Gifford, Mubadala, Felicis Ventures, Two Sigma Ventures.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 29 | 59% |
| Private equity | 3 | 6% |
| Accelerator & incubator | 1 | 2% |
| Other / undisclosed | 16 | 33% |
Hiring activity
Hires frequently
15 roles tracked across 6 of the last 12 months
10 Jun 2026 · Engineering Manager - Machine Learning · Salt Lake City
10 Jun 2026 · Vice President, Head of Clinical Operations · New York
10 Jun 2026 · Engineering Manager Machine Learning · Salt Lake City
10 Jun 2026 · Vice President Head of Clinical Operations · Salt Lake City
31 Mar 2026 · Director, Clinical Pharmacology · Salt Lake City
Based on job postings tracked across public sources.